A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
X-linked recessive myotubular myopathy (MTM1) is characterized by severe hypotonia and generalized muscle weakness, with impaired maturation of muscle fibres. We have restricted the candidate region to 280 kb and characterized two candidate genes using positional cloning strategies. The presence of frameshift or missense mutations (of which two are new mutations) in seven patients proved that one of these genes is indeed implicated in MTM1. The protein encoded by the MTM1 gene is highly conserved in yeast, which is surprising for a muscle specific disease. The protein contains the consensus sequence for the active site of tyrosine phosphatases, a wide class of proteins involved in signal transduction. At least three other genes, one located within 100 kb distal from the MTM1 gene, encode proteins with very high sequence similarities and define, together with the MTM1 gene, a new family of putative tyrosine phosphatases in man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The XLMTM is caused by mutations in the myotubularin 1 (MTM1) gene, located at Xq28.31”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [31]
In the citing paper
“Furthermore, mounting evidence shows that autophagy is regulated by distinct mechanisms in different cell types [11–26], and these cell type-specific mechanisms underlie the differential vulnerability of separate tissues to autophagy mutations, resulting in heterogenous manifestations of disease.”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
In the citing paper
“For instance, centronuclear myopathy is caused by mutations in the genes encoding MTM1 (myotubularin1) or MTMR14/Jumpy (myotubularin related protein 14) [17,20].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
In the citing paper
“These loss-of-function mutations prevent these enzymes from metabolizing phosphoinositides required for autophagy, thereby disinhibiting autophagy flux and muscle atrophy [17,20].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [17]
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans
Wilson, R., Ainscough, R., Anderson, K., Baynes, C., Berks, M., Bonfield, J., Burton, J., Connell, M., Copsey, T., Cooper, J., et al. (1994) · Nature · doi:10.1038/368032a0 · Cited by 1,465
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Self-citationProtein Tyrosine Phosphatases: A Diverse Family of Intracellular and Transmembrane Enzymes
Fischer, E. H., Charbonneau, H., & Tonks, N. K. (1991) · Science · doi:10.1126/science.1650499 · Cited by 956
Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach.
Uberbacher, E. C., & Mural, R. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11261 · Cited by 652
Sigma factors from E. coli, B. subtilis, phage SP01, and phage T4 are homologous proteins
Gribskov, M., & Burgess, R. R. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.16.6745 · Cited by 445
Hormones, Growth Factors, and Myogenic Differentiation
Florini, J. R., Ewton, D. Z., & Magri, K. A. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001221 · Cited by 423
Exon amplification: a strategy to isolate mammalian genes based on RNA splicing.
Buckler, A. J., Chang, D. D., Graw, S. L., Brook, J. D., Haber, D. A., Sharp, P. A., & Housman, D. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.4005 · Cited by 420
Research works printed but not linked: 1
- Lanfranchi, G. et al. Identification of 4,370 expressed sequence tags (ESTs) from a 3′-end specific cDNA library of human skeletal muscle by DNA sequencing and fitter hybridization. Genome Res. (in the press).
Cited by
Items 201–300 of 654
Kihara, A., Sakuraba, H., Ikeda, M., Denpoh, A., & Igarashi, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708993200 · Cited by 70
Probst, F. J., Roeder, E. R., Enciso, V. B., Ou, Z., Cooper, M. L., Eng, P., Li, J., Gu, Y., Stratton, R. F., Chinault, A. C., et al. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31781 · Cited by 60
“CMA is a new clinical diagnostic tool that can detect hundreds of different chromosomal deletions and duplications, including submicroscopic lesions that cannot be identified with routine chromosome analysis [Cheung et al., 2005; Lu et al., 2007].”
BackgroundInfluentialTsai, T.-C., Horinouchi, H., Noguchi, S., Minami, N., Murayama, K., Hayashi, Y. K., Nonaka, I., & Nishino, I. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.12.005 · Cited by 59
“XLMTM is MTM1, which encodes myotubularin, a phosphatidylinositol 3-phosphate phosphatase family [3].”
BackgroundResultInfluentialCommon Membrane Trafficking Defects of Disease‐Associated Dynamin 2 Mutations
Liu, Y., Lukiyanchuk, V., & Schmid, S. L. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01250.x · Cited by 63
“Another CNMcausing gene, myotubularin (19,66), is a lipid phosphatase that is important for regulating vesicle trafficking from the endosome to the lysosome (67,68).”
BackgroundThe myotubularin phosphatase MTMR4 regulates sorting from early endosomes
Naughtin, M. J., Sheffield, D. A., Rahman, P., Hughes, W. E., Gurung, R., Stow, J. L., Nandurkar, H. H., Dyson, J. M., & Mitchell, C. A. (2010) · Journal of Cell Science · doi:10.1242/jcs.060103 · Cited by 54
“Distinct MTMs might concentrate at discrete subcellular sites to degrade PtdIns(3)P on specific microdomains within the endosomal network, rather than degrade the total cellular levels of PtdIns(3)P levels per se (Laporte et al., 1996; Taylor et al., 2000; Tronchere et al., 2004).”
BackgroundMTMR9 Increases MTMR6 Enzyme Activity, Stability, and Role in Apoptosis
Zou, J., Chang, S.-C., Marjanovic, J., & Majerus, P. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804292200 · Cited by 57
In vivo cell biological screening identifies an endocytic capture mechanism for T-tubule formation
Hall, T. E., Martel, N., Ariotti, N., Xiong, Z., Lo, H. P., Ferguson, C., Rae, J., Lim, Y., & Parton, R. G. (2020) · Nature Communications · doi:10.1038/s41467-020-17486-w · Cited by 58
Early and severe presentation of X-linked myotubular myopathy in a girl with skewed X-inactivation
Jungbluth, H., Sewry, C. A., Buj‐Bello, A., Kristiansen, M. B., Örstavik, K. H., Kelsey, A. M., Manzur, A. Y., Mercuri, E. M., Wallgren‐Pettersson, C., & Muntoni, F. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00194-3 · Cited by 57
Gavriilidis, C., Laredj, L., Solinhac, R., Messaddeq, N., Viaud, J., Laporte, J., Sumara, I., & Hnia, K. (2018) · Nature Cell Biology · doi:10.1038/s41556-017-0024-9 · Cited by 56
Self-citationZhao, R., Qi, Y., Chen, J., & Zhao, Z. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5185 · Cited by 62
Amphiphysin 2 modulation rescues myotubular myopathy and prevents focal adhesion defects in mice
Lionello, V. M., Nicot, A.-S., Sartori, M., Kretz, C., Kessler, P., Buono, S., Djerroud, S., Messaddeq, N., Koebel, P., Prokic, I., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav1866 · Cited by 59
Self-citationViaud, J., Boal, F., Tronchère, H., Gaits‐Iacovoni, F., & Payrastre, B. (2013) · BioEssays · doi:10.1002/bies.201300132 · Cited by 59
“MTM1 is mutated in the centronuclear myopathy, a severe genetic disease linked to the X chromosome, leading to a defect in myotube maturation [40].”
BackgroundAnti-phosphatases take the stage
Tony, H. (1998) · Nature Genetics · doi:10.1038/ng0498-303 · Cited by 55
Mendelian disorders of PI metabolizing enzymes
Staiano, L., Leo, M. G. D., Persico, M., & Matteis, M. A. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.12.001 · Cited by 58
What's new in neuromuscular disorders? The congenital myopathies
Jungbluth, H., Sewry, C. A., & Muntoni, F. (2003) · European Journal of Paediatric Neurology · doi:10.1016/s1090-3798(02)00136-8 · Cited by 54
An integrated modelling methodology for estimating the prevalence of centronuclear myopathy
Vandersmissen, I., Biancalana, V., Servais, L., Dowling, J. J., Stichele, G. V., Rooijen, S. V., & Thielemans, L. A. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2018.06.012 · Cited by 53
Nandurkar, H. H., Caldwell, K. K., Whisstock, J. C., Layton, M. J., Gaudet, E. A., Norris, F. A., Majerus, P. W., & Mitchell, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171306098 · Cited by 59
McClelland, V. M., Cullup, T., Bódi, I., Ruddy, D., Buj‐Bello, A., Biancalana, V., Böhm, J., Bitoun, M., Miller, O., Jan, W., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33296 · Cited by 53
“…of central nuclei on muscle biopsy, screening of major genes previously associated with CNM (myotubular) including the myotubularin (MTM1) [Laporte et al., 1996], dynamin 2 (DNM2) [Bitoun et al., 2005], and amphiphysin 2 (BIN1) [Nicot et al., 2007] genes was performed as previously…”
BackgroundInfluentialSelf-citationMacůrková, M., Port, F., Harterink, M., Basler, K., & Korswagen, H. C. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.278 · Cited by 55
“In humans, members of the myotubularin family have been implicated in several disorders, such as myotubular myopathy (Laporte et al, 1996), peripheral neuropathies (Bolino et al, 2000; Azzedine et al, 2003; Senderek et al, 2003) and azoospermia (Firestein et al, 2002).”
BackgroundMyotubularin Phosphoinositide Phosphatases in Human Diseases
Amoasii, L., Hnia, K., & Laporte, J. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-94-007-5025-8_10 · Cited by 54
“Myotubularin (MTM1), the pioneer member of myotubularins, was discovered by positional cloning as the gene mutated in X-linked centronuclear myopathy (Laporte et al., 1996).”
BackgroundSelf-citationRegulation of Sertoli Cell Myotubularin (rMTM) Expression by Germ Cells In Vitro
Li, J. C. H., Lee, W. M., Mruk, D. D., & Cheng, C. Y. (2001) · Journal of Andrology · doi:10.1002/j.1939-4640.2001.tb02180.x · Cited by 52
Loudianos, G., Dessi, V., Lovicu, M., Angius, A., Figus, A., Lilliu, F., De Virgiliis, S., Nurchi, A. M., Deplano, A., Moi, P., et al. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(199910)14:4<294::aid-humu4>3.0.co;2-9 · Cited by 166
Self-citationMochizuki, Y., Ohashi, R., Kawamura, T., Iwanari, H., Kodama, T., Naito, M., & Hamakubo, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.395087 · Cited by 51
“MTM1(2) was first identified as the gene responsible for X-linked myotubular myopathy, a severe or fatal muscle weakness in male infants (1).”
BackgroundCentronuclear myopathies under attack: A plethora of therapeutic targets
Tasfaout, H., Cowling, B. S., & Laporte, J. (2018) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-180309 · Cited by 52
“In addition, the elevated level of the MTM1 substrate phosphoinositol-3-phosphate (PtdIns3P) in Mtm1KO muscles was corrected upon this treatment.”
BackgroundInfluentialSelf-citationIs prenatal myo‐inositol deficiency a mechanism of CNS injury in galactosemia?
Berry, G. T. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9260-x · Cited by 54
A clinical and genetic study of a manifesting heterozygote with X-linked myotubular myopathy
Hammans, S. R., Robinson, D., Moutou, C., Kennedy, C., Dennis, N. R., Hughes, P., & Ellison, D. W. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00073-5 · Cited by 50
Deletion Xq27.3q28 in female patient with global developmental delays and skewed X-inactivation
Marshall, L. S., Simon, J., Wood, T. C., Peng, M., Owen, R. X., Feldman, G. S., & Zaragoza, M. V. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-49 · Cited by 49
“The deletion of MTM1 gene may be associated with our patient’s hyptonia as MTM1 deletions and mutations have been shown to be related to myotubular myopathy [35].”
BackgroundDiagnosis of pediatric neuromuscular disorders in the era of DNA analysis
Darras, B. T., & Jones, H. R. (2000) · Pediatric Neurology · doi:10.1016/s0887-8994(00)00202-2 · Cited by 52
“[49] Laporte J, Hu LJ, Kretz C, et al.”
BackgroundMyofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy
Pierson, C. R., Agrawal, P. B., Blasko, J., & Beggs, A. H. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.03.010 · Cited by 49
“XLMTM is the best studied of the centronuclear myopathies (CNM) and it is characterized by an increased proportion of hypotrophic myofibers with centrally placed nuclei on muscle biopsy [1–4].”
BackgroundX-linked myotubular myopathy — A long-term follow-up study
Barth, P. G., & Dubowitz, V. (1998) · European Journal of Paediatric Neurology · doi:10.1016/1090-3798(98)01004-9 · Cited by 49
Myotubularin-Related (MTMR) Phospholipid Phosphatase Proteins in the Peripheral Nervous System
Bolis, A., Zordan, P., Coviello, S., & Bolino, A. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0031-0 · Cited by 51
Congenital myopathies: not only a paediatric topic
Jungbluth, H., & Voermans, N. C. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000372 · Cited by 48
“CNM has been associated with X-linked recessive mutations in MTM1 encoding myotubularin [“X-linked myotubular myopathy (XLMTM)”] [39], autosomal-dominant mutations in DNM2 encoding dynamin2 [40] and the BIN1 gene encoding amphiphysin 2 [41], and autosomal-recessive mutations in BIN1 [42], RYR1 encoding the skeletal mu…”
BackgroundCurrent and future therapeutic approaches to the congenital myopathies
Jungbluth, H., Ochala, J., Treves, S., & Gautel, M. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.004 · Cited by 50
“CNM is due to X-linked recessive mutations in TM1 encoding myotubularin [“X-linked myotubular myopathy XLMTM)”] [47], autosomal-dominant mutations in DNM2 encodng dynamin2 [48] and the BIN1 gene encoding amphiphysin 2 [49], utosomal-recessive mutations in BIN1 [50], RYR1 [14], and TTN ncoding titin [51], and rarer bac…”
BackgroundRegional and Developmental Expression of Epm2a Gene and Its Evolutionary Conservation
Ganesh, S., Agarwala, K. L., Amano, K., Suzuki, T., Delgado‐Escueta, A. V., & Yamakawa, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4914 · Cited by 48
Linkage analysis in Rett syndrome families suggests that there may be a critical region at Xq28.
Webb, T., Clarke, A., Hanefeld, F., Pereira, J. L., Rosenbloom, L., & Woods, C. G. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.12.997 · Cited by 48
X-inactivation patterns in carriers of X-linked myotubular myopathy
Kristiansen, M. B., Knudsen, G. P., Tanner, S. M., McEntagart, M., Jungbluth, H., Muntoni, F., Sewry, C. A., Gallati, S., Örstavik, K. H., & Wallgren‐Pettersson, C. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00067-1 · Cited by 47
Tosch, V., Vasli, N., Kretz, C., Nicot, A.-S., Gasnier, C., Dondaine, N., Oriot, D., Barth, M., Puissant, H., Romero, N. B., et al. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.03.015 · Cited by 46
“expressed and a specific protein isoform is present in muscles [10,20].”
BackgroundSelf-citationInositol Phosphates and Phosphoinositides in Health and Disease
Shi, Y. H., Azab, A. N., Thompson, M. N., & Greenberg, M. L. (2006) · Springer eBooks · doi:10.1007/0-387-27600-9_11 · Cited by 54
Tanner, S. M., Schneider, V., Thomas, N. S. T., Clarke, A. J., Lazarou, L., & Liechti‐Gallati, S. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(98)00090-x · Cited by 46
“The disease locus for XLMTM has been localized to proximal Xq28 [5–12], and the gene responsible, MTM1, was recently isolated [13].”
BackgroundManring, H., Abreu, E., Brotto, L., Weisleder, N., & Brotto, M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00037 · Cited by 44
Choudhury, P., Srivastava, S., Li, Z., Ko, K. A., Albaqumi, M. N., Narayan, K., Coetzee, W. A., Lemmon, M. A., & Skolnik, E. Y. (2006) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84091-7 · Cited by 45
Dysregulation of NRAP degradation by KLHL41 contributes to pathophysiology in nemaline myopathy
Jirka, C., Pak, J. H., Grosgogeat, C. A., Marchetii, M. M., & Gupta, V. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz078 · Cited by 44
Liewluck, T., Lovell, T. L., Bite, A. V., & Engel, A. G. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.07.273 · Cited by 43
“In MTM1-CNM the myonuclei appear adjacent to the necklace in a bead-like pattern, but in our DNM2-CNM patient the nuclei remain central [8].”
BackgroundInfluentialA review of major causative genes in congenital myopathies
Ogasawara, M., & Nishino, I. (2022) · Journal of Human Genetics · doi:10.1038/s10038-022-01045-w · Cited by 44
“A clinical study on the utility of tamoxifen in patients with XLMTM has been recently launched (TAM4MTM, NCT04915846).”
BackgroundInfluentialA Brief Introduction to the Protein Phosphatase Families
Mustelin, T. (2007) · Humana Press eBooks · doi:10.1385/1-59745-267-x:9 · Cited by 48
Lawlor, M. W., Viola, M. G., Meng, H., Edelstein, R. V., Liu, F., Yan, K., Luna, E. J., Lerch-Gaggl, A., Hoffmann, R. G., Pierson, C. R., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.03.003 · Cited by 43
Novel findings associated with MTM1 suggest a higher number of female symptomatic carriers
Savarese, M., Musumeci, O., Giugliano, T., Rubegni, A., Fiorillo, C., Fattori, F., Torella, A., Battini, R., Rodolico, C., Pugliese, A., et al. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.02.004 · Cited by 42
Genetic therapies for inherited neuromuscular disorders
Scoto, M., Finkel, R. S., Mercuri, E. M., & Muntoni, F. (2018) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30140-8 · Cited by 45
Update on the Genetics of Congenital Myopathies
Pelin, K., & Wallgren‐Pettersson, C. (2019) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2019.01.005 · Cited by 42
Membrane targeting and remodeling through phosphoinositide‐binding domains
Takenawa, T., & Itoh, T. (2006) · IUBMB Life · doi:10.1080/15216540600732039 · Cited by 48
Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation
Jungbluth, H., Cullup, T., Lillis, S., Zhou, H., Abbs, S. J., Sewry, C. A., & Muntoni, F. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.10.005 · Cited by 42
“The X-linked form (‘‘myotubular myopathy”) is due to mutations in the myotubularin (MTM1) gene [2] in the majority of affected males and in rare females with skewed X-inactivation [3,4], whilst more recently a proportion of autosomal dominant and recessive cases have been linked to mutations in the dynamin 2 (DNM2) [5…”
BackgroundThe role of immunocytochemistry in congenital myopathies
Sewry, C. A. (1998) · Neuromuscular Disorders · doi:10.1016/s0960-8966(98)00053-4 · Cited by 44
“One gene for myotubular myopathy on Xq28 has been identified but the gene(s) for the autosomal form(s) are unknown [18].”
BackgroundWagner, K. R. (2002) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00002-6 · Cited by 45
“X-linked myotubular myopathy (MTMX) is a distinct disorder caused by mutations in the gene for myotubularin on chromosome Xq28 [128].”
BackgroundMyopathology in times of modern imaging
Jungbluth, H. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12385 · Cited by 40
Gupta, V. A., Hnia, K., Smith, L. L., Gundry, S. R., McIntire, J. E., Shimazu, J., Bass, J. R., Talbot, E. A., Amoasii, L., Goldman, N. E., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003583 · Cited by 38
Self-citationCongenital myopathies and related disorders
Taratuto, A. L. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200210000-00006 · Cited by 40
Firestein, R., & Cleary, M. L. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.16.2921 · Cited by 40
X-linked myotubular myopathy in a female infant caused by a new MTM1 gene mutation
Schara, U., Kreß, W., Tücke, J., & Mortier, W. (2003) · Neurology · doi:10.1212/01.wnl.0000058763.90924.fa · Cited by 40
Recommendations for a nomenclature system for human gene mutations
Antonarakis, S. E., & Nomenclature Working Group (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:1<1::aid-humu1>3.0.co;2-o · Cited by 943
Self-citationValladares, A., Porrás, A., Alvarez, A. M., Roncero, C., & Benito, M. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200012)185:3<408::aid-jcp11>3.0.co;2-2 · Cited by 26
Ghasemizadeh, A., Christin, E., Guiraud, A., Couturier, N., Abitbol, M., Risson, V., Girard, E., Jagla, C., Soler, C., Laddada, L., et al. (2021) · eLife · doi:10.7554/elife.70490 · Cited by 42
“Genes implicated in the various forms of CNMs encode proteins that participate in different aspects of membrane remodeling and trafficking such as MTM1, Amphyphisin-2/BIN1, DNM2, and HACD1 ( Bitoun et al., 2005 ; Laporte et al., 1996 ; Muhammad et al., 2013 ; Muller et al., 2003 ).”
Congenital myopathies - a comprehensive update of recent advancements
Sharma, M. C., Jain, D., Sarkar, C., & Goebel, H. H. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01126.x · Cited by 39
“Genetically the XLMTM is a homogenous disorder known to be characterized by more than 130 mutations (57), and assigned to XLMTM gene at Xq28 (58, 59) which encodes myotubularin, a family of tyrosine phosphatase.”
BackgroundLi, D., Gonzalez, O., Bachinski, L. L., & Roberts, R. (2000) · Gene · doi:10.1016/s0378-1119(00)00347-4 · Cited by 40
Uwanogho, D., Hardcastle, Z., Balogh, P., Mirza, G. K., Thornburg, K. L. R., Ragoussis, J., & Sharpe, P. T. (1999) · Genomics · doi:10.1006/geno.1999.5950 · Cited by 39
Tiret, L., Blot, S., Kessler, J.-L., Gaillot, H., Breen, M., & Panthier, J. (2003) · Human Genetics · doi:10.1007/s00439-003-0984-7 · Cited by 41
“The X-linked myotubular myopathy (XLMTM) in human has been shown to result from mutations in MTM1 ( Laporte et al. 1996, 2000; Biancalana et al. 2003), which encodes myotubularin, a protein that belongs to a well-conserved eukaryotic phosphatase family with at least 14 related members in human (MTMR1–13 and 3-PAP; Lap…”
BackgroundLee, H. W., Kim, Y., Han, K., Kim, H., & Kim, E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4283-09.2010 · Cited by 41
“MTM1, MTMR2, and MTMR13 have been associated with myopathy and neuropathies, highlighting their clinical importance (Laporte et al., 1996; Bolino et al., 2000; Azzedine et al., 2003; Senderek et al., 2003; Berger et al., 2006a; Previtali et al., 2007; Nicot and Laporte, 2008).”
BackgroundPTEN and Myotubularins: Families of Phosphoinositide Phosphatases
Taylor, G. S., & Dixon, J. E. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)66004-0 · Cited by 43
Insights from genotype–phenotype correlations by novel SPEG mutations causing centronuclear myopathy
Wang, H., Claudia Castiglioni, T., Bayram, A. K., Fattori, F., Pekuz, S., Araneda, D., Per, H., Torricelli, R. E., Gümüş, H., Zorludemir, S., et al. (2017) · Neuromuscular Disorders · doi:10.1016/j.nmd.2017.05.014 · Cited by 36
Kutchukian, C., Szentesi, P., Allard, B., Trochet, D., Beuvin, M., Berthier, C., Tourneur, Y., Guicheney, P., Csernoch, L. J., Bitoun, M., et al. (2017) · The Journal of Physiology · doi:10.1113/jp274990 · Cited by 36
“Most well-known mutations responsible for CNMs affect the genes encoding myotubularin (MTM1; Laporte et al. 1996), amphiphysin 2 (BIN1; Nicot et al.”
BackgroundSztretye, M. T., Szabó, L. Z., Dobrosi, N., Fodor, J., Szentesi, P., Almássy, J., Magyar, Z. É., Dienes, B., & Csernoch, L. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238935 · Cited by 36
Oliveira, J., Oliveira, M. E., Kreß, W., Taipa, R. J. F., Pires, M. M., Hilbert, P., Baxter, P., Santos, M., Buermans, H. P. J., den Dunnen, J. T., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.201 · Cited by 36
Management of Congenital Diaphragmatic Hernia (CDH): Role of Molecular Genetics
Cannata, G., Caporilli, C., Grassi, F., Perrone, S., & Esposito, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126353 · Cited by 34
“Myotubular Myopathy 1 (OMIM 310400) Myotubular myopathy 1 (MTM1) is an X-linked recessive centronuclear myopathy due to loss of function mutations in the myotubularin 1 (MTM1) at Xq28 [145].”
BackgroundLin, X., Yang, X., Li, Q., Ma, Y., Cui, S., He, D., Lin, X., Schwartz, R. J., & Chang, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05484-11 · Cited by 34
“For example, mutations in myotubularin 1, a PTPase encoded by the MTM1 (myotubular myopathy) gene in humans, is responsible for X-linked centronuclear myopathy in humans and canines (8, 35, 36).”
BackgroundPénisson-Besnier, I., Biancalana, V., Reynier, P., Cossée, M., & Dubas, F. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.10.008 · Cited by 34
“X-linked myotubular myopathy (XLMTM) is a rare congenital muscle disorder due to mutation in the MTM1 gene, encoding myotubularin [1].”
BackgroundThe significance of type 1 fiber atrophy (hypotrophy) in childhood neuromuscular disorders
Imoto, C., & Nonaka, I. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00213-3 · Cited by 34
Myotubular myopathy: morphological, immunohistochemical and clinical variation
Helliwell, T. R., Ellis, I. H., & Appleton, R. E. (1998) · Neuromuscular Disorders · doi:10.1016/s0960-8966(98)00010-8 · Cited by 34
“[2] defined the location of the MTM gene in a 430-kb region flanked by markers DXS304 and DXS497, and the gene was identified within Xq28 [4].”
BackgroundInfluentialExpression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy
Raess, M. A., Cowling, B. S., Bertazzi, D. L., Kretz, C., Rinaldi, B., Xuereb, J.-M., Kessler, P., Romero, N. B., Payrastre, B., Friant, S., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx258 · Cited by 35
“In human, mutations in MTM1 cause the severe congenital myopathy called myotubular myopathy [or X-linked centronuclear myopathy (XLCNM); OMIM 310400] (16), while mutations in either the active MTMR2 or the dead-phosphatase MTMR13 cause CharcotMarie-Tooth (CMT) peripheral neuropathies (CMT4B1, OMIM 601382 and CMT4B2, O…”
BackgroundSelf-citationCooperation of Mtmr8 with PI3K Regulates Actin Filament Modeling and Muscle Development in Zebrafish
Mei, J., Li, Z., & Gui, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004979 · Cited by 35
“Mutations or altered expression of PTEN or MTM family members have been observed in human cancers[11–13] and in genetic development defects[14,15].”
BackgroundPhospholamban overexpression in mice causes a centronuclear myopathy-like phenotype
Fajardo, V. A., Bombardier, É., McMillan, E. M., Tran, K., Wadsworth, B. J., Gamu, D., Hopf, A., Vigna, C., Smith, I. C. P., Bellissimo, C. A., et al. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.020859 · Cited by 40
“…et al., 2014; Jungbluth and Gautel, 2014) and have been attributed to X-linked recessive mutations in the MTM1 gene encoding myotubularin (Laporte et al., 1996), autosomal-dominant mutations in the DNM2 gene encoding dynamin-2 (Bitoun et al., 2005) and the BIN1 gene encoding…”
Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset
Melberg, A., Kretz, C., Kalimo, H., Wallgren‐Pettersson, C., Toussaint, A., Böhm, J., Stålberg, E., & Laporte, J. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.10.006 · Cited by 32
“Centronuclear (myotubular) myopathy (CNM) is genetically and clinically heterogeneous [1]; X-linked inheritance is caused by myotubularin (MTM1) gene mutations [2–4], autosomal dominant inheritance is caused by heterozygous dynamin 2 (DNM2) gene mutations [5], and some cases with autosomal recessive inheritance are ca…”
Self-citationBachmann, C., Jungbluth, H., Muntoni, F., Manzur, A. Y., Zorzato, F., & Treves, S. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw388 · Cited by 40
“Symptoms are typically present at birth and without ventilator support most affected males die within the first year of life, though some infants have a milder presentation with less severe onset and survive into early childhood or adolescence (1,2,8,9).”
BackgroundPhosphatidylinositol-3,5-bisphosphate: metabolism and physiological functions
Takasuga, S., & Sasaki, T. (2013) · The Journal of Biochemistry · doi:10.1093/jb/mvt064 · Cited by 35
Hnia, K., Kretz, C., Amoasii, L., Böhm, J., Liu, X., Messaddeq, N., Qu, C., & Laporte, J. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.09.007 · Cited by 32
Self-citationExtensive morphological and immunohistochemical characterization in myotubular myopathy
Shichiji, M., Biancalana, V., Fardeau, M., Hogrel, J., Ōsawa, M., Laporte, J., & Romero, N. B. (2013) · Brain and Behavior · doi:10.1002/brb3.147 · Cited by 36
“We found a similar morphological pattern throughout the period analyzed; the proportion of myofibers with central nuclei was high in all muscle biopsies, independently of the muscle type, the age of the newborns at time of biopsy and the specific MTM1 mutation.”
BackgroundSelf-citationBridging integrator 1 (Bin1) deficiency in zebrafish results in centronuclear myopathy
Smith, L. L., Gupta, V., & Beggs, A. H. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu067 · Cited by 33
“Pathogenic CNM mutations are most commonly reported in the phosphoinositide (PI) phosphatase myotubularin (MTM1) and the large GTPase dynamin 2 (DNM2) genes, resulting in neonatal X-linked (CNMX; MIM #310400) and autosomal dominant (CNM1; MIM #160150) forms of the disease, respectively (1,2).”
BackgroundThe CMT4B disease-causing proteins MTMR2 and MTMR13/SBF2 regulate AKT signalling
Berger, P., Tersar, K., Ballmer‐Hofer, K., & Suter, U. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00967.x · Cited by 38
“Mutations in myotubularin, the founding member of the Mtmr family, lead to X-linked myotubular myopathy [1].”
BackgroundSPEG-deficient skeletal muscles exhibit abnormal triad and defective calcium handling
Huntoon, V., Widrick, J. J., Sanchez, C., Rosen, S. M., Kutchukian, C., Cao, S., Pierson, C. R., Liu, X., Perrella, M. A., Beggs, A. H., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy068 · Cited by 32
New era in genetics of early-onset muscle disease: Breakthroughs and challenges
Ravenscroft, G., Davis, M. R., Lamont, P. J., Forrest, A. R. R., & Laing, N. G. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.002 · Cited by 31
“Traditionally the centronuclear myopathies have included X-linked centronuclear myopathy (CNMX, OMIM 310400) due to myotubularin gene (MTM1, OMIM 300415) mutation [13] and typically milder forms due to autosomal dominant mutations of dynamin 2 (DNM2, CNM1, OMIM 160150) [14] or autosomal recessive mutation of amphiphys…”
BackgroundBIN1 modulation in vivo rescues dynamin-related myopathy
Lionello, V. M., Kretz, C., Edelweiss, E. F., Crucifix, C., Gómez, R., Messaddeq, N., Buono, S., Koebel, P., Massana-Muñoz, X., Diedhiou, N., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109576119 · Cited by 31
“Apart from DNM2, loss-of-function mutations in the membrane remodeling protein amphiphysin 2 (BIN1; MIM [Mendelian Inheritance in Man]# 255200) (10), in the lipid phosphatase myotubularin (MTM1; MIM#310400) (11) and in the triad calcium channel ryanodine receptor (RYR1; MIM#117000) (12–14), lead to CNMs.”
BackgroundSelf-citationMaurer, M., Mary, J. E., Guillaud, L., Fender, M., Pelé, M., Bilzer, T., Olby, N. J., Penderis, J., Shelton, G. D., Panthier, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046408 · Cited by 35
“uk and [3]).”
Gene Therapy for Inherited Muscle Diseases: Where Genetics Meets Rehabilitation Medicine
Braun, R. G., Wang, Z., Mack, D. L., & Childers, M. K. (2014) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000138 · Cited by 37
Growth stimulation of primary B cell precursors by the anti-phosphatase Sbf1
Vivo, I. D., Cui, X., Domen, J., & Cleary, M. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9471 · Cited by 35
He, D., Liu, H., Wei, W., Zhao, Y., Cai, Q., Shi, S., Chu, X., Qin, X., Zhang, N., Xu, P., et al. (2023) · Osteoporosis International · doi:10.1007/s00198-023-06852-1 · Cited by 30
“As a catalytically inactive member of the myotu-bularin family, MTMR12 interacts with MTM1 and MTMR2 to regulate their subcellular localization and plays a role in X-linked myotubular myopathy (XLMTM) [41–43].”
Backgroundthe NatHis-MTM Study Group, Fouarge, E., Monseur, A., Boulanger, B., Annoussamy, M., Seferian, A., Lucia, S. D., Lilien, C., Thielemans, L. A., Paradis, K., et al. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01663-7 · Cited by 31
“The main causal mutations are distributed throughout the genes encoding myotubularin (MTM1) for XLMTM (OMIM: 310400) [24], dynamin 2 (DNM2) [25] and amphiphysin 2 (BIN1) [26] for the autosomal dominant form (OMIM: 160150), and amphiphysin 2 (BIN1) [27] for the autosomal recessive form (OMIM: 255200).”
BackgroundFranklin, N. E., Taylor, G. S., & Vacratsis, P. O. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.209122 · Cited by 35
Ca2+ handling abnormalities in early-onset muscle diseases: Novel concepts and perspectives
Treves, S., Jungbluth, H., Voermans, N. C., Muntoni, F., & Zorzato, F. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.07.017 · Cited by 34
Zhang, J., Mruk, D. D., & Cheng, C. Y. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20303 · Cited by 31
“The first member of the myotubularin family, myotubularin (MTM1/MTM) was identified and cloned in 1996 in the human (Laporte et al., 1996).”
BackgroundFYVE-DSP1, a Dual-Specificity Protein Phosphatase Containing an FYVE Domain
Zhao, R., Qi, Y., & Zhao, Z. J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2417 · Cited by 30
Abnormal Excitation-Contraction Coupling and Calcium Homeostasis in Myopathies and Cardiomyopathies
Schartner, V., Laporte, J., & Böhm, J. (2019) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-180314 · Cited by 32
“…(or centronuclear) myopathy (XLMTM, OMIM #310400), a severe and generalized neonatal muscle disorder predominantly affecting boys and involving atrophic muscle fibers, type I fiber predominance, centralized nuclei, and sometimes basophilic rings known as necklace fibers on muscle biopsies [116, 117].”
BackgroundSelf-citationGoryunov, D., Nightingale, A., Bornfleth, L., Leung, C. L., & Liem, R. K. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05103.x · Cited by 29
“Interestingly, muscle MTM1 mRNA is smaller than MTM1 mRNA expressed in other tissues because of an alternate polyadenylation site (Laporte et al. 1996, 1998).”
Background
Metadata
- Authors
- Laporte, J., Hu, L. J., Kretz, C., Mandel, J.-L., Kioschis, P., Coy, J. F., Klauck, S. M., Poustka, A., & Dahl, N.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- German Cancer Research Center (DE)
- Uppsala University (SE)
- Venue
- Nature Genetics
- Published
- 1996-06
- Volume
- 13
- Issue
- 2
- Pages
- 175-182
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1984366092
- Cited by
- 639
- References
- 51
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 20 · 2023: 16 · 2022: 19 · 2021: 23 · 2020: 21 · 2019: 26 · 2018: 25 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 28 · 2013: 35 · 2012: 26
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- X-linked myotubular myopathy, MTM1 gene, positional cloning, frameshift mutation, missense mutations, yeast homolog, hypotonia, signal transduction, conserved protein families
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Binding Sites, Cloning, Molecular, Genes, Fungal, Humans, Genetic Linkage, Molecular Sequence Data, Muscle Hypotonia, Muscular Diseases, Mutation, Saccharomyces cerevisiae, Tissue Distribution, X Chromosome, Protein Tyrosine Phosphatases, Conserved Sequence, Caenorhabditis elegans, Protein Tyrosine Phosphatases, Non-Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.